2018, Number 2
<< Back Next >>
Rev Mex Oftalmol 2018; 92 (2)
Rapid assessment of avoidable blindness including diabetic tetinopathy in Queretaro, Mexico
López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, LansinghVC
Language: Spanish
References: 18
Page: 84-93
PDF size: 145.06 Kb.
ABSTRACT
Objective: To determine the prevalence and causes of blindness and visual impairment and the prevalence of diabetes and
diabetic retinopathy (DR) in the state of Querétaro, México.
Materials and Methods: 180 clusters of 35 people aged ≥ 50 years
were randomly selected. Participants had their visual acuity measured and lens examined and had a random blood glucose test
to assess their diabetes status. Participants with diabetes had a dilated fundus examination and digital fundus photographs taken.
DR was graded using the Scottish DR grading system.
Results: The prevalence of blindness among the 5,935 survey participants
was 1.0% (95% confidence interval [CI]: 0.7–1.2%). The sample prevalence of severe, moderate, and early visual impairment and
functional low vision were 1.6, 3.2, 12.7, and 1.4%, respectively. The most common cause of blindness was cataract representing 29.8% of the cases, followed by DR (17.5%). The most common cause of functional low vision was DR (32.9%). There were 1,115
participants with diabetes (18.8%; 95% CI: 17.4-20.2%), 92 of whom were newly diagnosed during this study. The prevalence of
retinopathy and/or maculopathy among these patients was 22.5% (95% CI: 19.0–26.1%), and 3.6% (95% CI: 2.4–4.8%) had
sight-
threatening DR.
Conclusion: Although cataract is the primary cause of blindness among people aged ≥ 50 years in Querétaro,
México, DR is the second cause of blindness and the leading cause of functional low vision. There is a need to expand
and improve eye care services in Querétaro and to ensure early diagnosis and treatment of diabetes and DR.
REFERENCES
Stevens GA, White RA, Flaxman SR, et al. On behalf of the Vision Loss Expert Group. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013; 120(12):2377-84.
Instituto Nacional de Salud Pública (México). Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. 2.ª ed., 2013 [online] (consultado el 20 de septiembre de 2016). Disponible en: http://ensanut. insp.mx/informes/ENSANUT2012ResultadosNacionales2Ed.pdf
Limburg H, Barria von Bischoffshausen F, Gómez P, Silva JC, Foster A. Review of recent surveys on blindness and visual impairment in Latin America. Br J Ophthalmol. 2008;92(3):315-9.
Limburg H, Silva JC, Foster A. Cataract in Latin America: Findings from nine recent surveys. Rev Panam Salud Publica. 2009;25(5):449-55.
Polack S, Yorston D, López-Ramos A, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, México. Ophthalmology. 2012;119(5):1033-40.
The World Bank. Data. Countries and Economies [online] (consultado el 20 de septiembre de 2016). Disponible en: http://data.worldbank.org/country
Consejo Nacional de Evaluación de la Política de Desarrollo Social (México). Medición de la Pobreza [online] (consultado el 19 de septiembre de 2016). Disponible en: http://www.coneval.org.mx/Medicion/MP/ Paginas/Pobreza_2014.aspx
International Diabetes Federation (IDF). IDF Diabetes Atlas – 7.ª ed., 2015 [online] (consultado el 19 de septiembre de 2016). Disponible en: http://www.diabetesatlas.org/across-the-globe.html
London School of Hygiene and Tropical Medicine International Centre for Eye Health. Rapid Assessment of Avoidable Blindness, 2016 [online] (consultado el 19 de septiembre de 2016). Disponible en: http://iceh.lshtm. ac.uk/rapid-assessment-of-avoidable-blindness
Notimex. Representa la diabetes primera causa de muerte en Querétaro. Noticias MVS. 13 de noviembre de 2013 [online] (consultado el 19 de septiembre de 2016). Disponible en: http://www.noticiasmvs.com/#!/noticias/ representa-la-diabetes-primera-causa-de-muerte-en-queretaro-255.html
Instituto Nacional de Estadística y Geografía (México). Censo de Población y Vivienda 2010 [online] (consultado el 23 de septiembre de 2016). Disponible en: http://www.inegi.org.mx/est/contenidos/proyectos/ccpv/ cpv2010/Default.aspx
Instituto Nacional de Estadística y Geografía (México). Cuéntame. Información por entidad: Querétaro. Distribución (consultado el 18 de julio de 2017). Disponible en: http://cuentame.inegi.org.mx/monografias/informacion/ queret/poblacion/distribucion.aspx?tema=me&e=22
World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) – WHO Version for 2016 [online] (consultado el 23 de septiembre de 2016). Disponible en: http://apps.who.int/classifications/icd10/browse/2016/en#/H53-H54
Scottish Diabetic Retinopathy Screening Collaborative. Scottish Diabetic Retinopathy Grading Scheme 2007 v1.1 [online] (consultado el 26 de septiembre de 2016). Disponible en: http://www.ndrs-wp.scot.nhs.uk/ wp-content/uploads/2013/04/Grading-Scheme-2007-v1.1.pdf
Limburg H, Meester W, Polack S. RAAB6. International Centre for Eye Health, London School of Hygiene % Tropical Medicine, 2015 [on line] (consultado el 26 de septiembre de 2016). Disponible en: http://www. cehjournal.org/resources/raab
Kumar A, Wong R, Ottenbacher KJ, Al Snih S. Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican Health and Aging Study. Ann Epidemiol. 2016;26(3):163-70.
Cepeda-Nieto AC, Esquivel-Contreras MT, Duran-Iñiguez F, et al. High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern México. Exp Ther Med. 2015;10(2):435-44.
United States Census Bureau. International Data Base, 2016 [online] (consultado el 23 de septiembre de 2016). Disponible en: https://www. census.gov/population/international/data/idb/informationGateway.php